Page 1,647«..1020..1,6461,6471,6481,649..1,6601,670..»

Will Trump stick with TrumpCare? – Fox News

Posted: March 9, 2017 at 6:47 am

**Want FOX News Halftime Report in your inbox every day? Sign uphere.**

On the roster: Will Trump stick with TrumpCare?- Whodunnit? CIA chasing culprit in damaging breach- Ill Tell You What: Health fibs and panda ribs- Nerd Bracket: The Flourishing Four- He only reads it for the ordinances

WILL TRUMP STICK WITH TRUMPCARE? President Trumpisreportedly headingto Louisville this weekend and its not to get a head start on handicapping the Derby.

The Bluegrass State is home toone ofthe many critics of Trumps newly proposed overhaul of Americas health care system, Sen.Rand Paul, who was one of Trumps most detested rivals during the 2016 Republican primaries.

Paul could be feeling the squeeze. Trump won 63 percent of the vote in Pauls commonwealth, a full 6 points better than Paul did in his re-election bid last year. Trump can also apply some friendlier pressure to Pauls Kentucky colleague, Senate Majority LeaderMitch McConnell, while hes at it.

And if the President means to see his first major policy initiative succeed, his weekends are going to look a lot like this and less like Mar-A-Lago golf outings for some time to come.

Trumps legislation is unpopular, but then again any replacement for ObamaCare was going to be unpopular.

Now, thats not to say that they couldnt have come up with something better than this, which is both simultaneously unambitious and flinty. But lets face facts: this was never going to be easy.

The components of this legislation reveal the audience of one for whom the bill was written, the president of the United States.

SpeakerPaul Ryanandthe House leadership team, working in conjunction with Health and Human Services SecretaryTom Price,have months to work on cutting side deals with specific caucuses and interest groups but without Trump they cannot succeed.

But Trump cannot succeed without this bill.

It only took a day for the moniker TrumpCare to adhere to this plan. Thats good news for Ryan & Co. since they will need the presidents unflagging support and undivided attention to jam and cram the legislation through.

Getting Trump and the White House on the record with full-throated support was the first and, arguably, mainobjective in preventing legislative disaster. The legislation already looks to be on life support, but a more tepid response by Trump would have put the plan straight in the morgue.

Instead, now the president owns it and its success or failure will be determined in the largest part by his gifts as a salesman and an enforcer.

Paul makes an interesting case study, much like his fellow critics Sen.Shelly Moore Capito, R-W.Va.,and Sen.Tom Cotton, R-Ark. They are conservative Republicans who have reasons to oppose the hyper-regulatory approach of the proposed law but also represent states that would suffer considerably under its slated elimination of Medicaid coverage.

They are doubly motivated to kill the bill, and Trump provides the only counterweight.

If the law is to pass, there will be considerable deal making at the end. But, to get to that point Trump will have to deploy political brute force. Trump extols the rebellious virtues ofAndrew Jackson, but it is the backroom badgering ofLyndon Johnsonthat the 45thpresident will need to emulate right now.

Other than his pride, what Trump has on the line now is no less than the entirety of his ambitious agenda.

If this measure fails, which it surely could, Trump can kiss goodbye his plans for overhauling the tax code and a trillion-dollar infrastructure spending package. Ryan and the rest of the Republican leadership have to now hope that Trump sees it the same way.

What remains to be seen is if Trump, famously mercurial, will stick with the already-unpopular plan as the seas get heavier.

Remember, the negotiations and sweeteners come later. If Trump cant enforce party discipline in the opening phase of this bill, there will be no deals to be made at the end because there will be no bill. RYAN TRIES TO RALLY CONSERVATIVES FOR TRUMPCARE WaPo:House SpeakerPaul D. Ryan(R-Wis.) sought on Wednesday to stem the tide of resistance to a Republican proposal to revise the Affordable Care Act, calling his plan a conservative wish list that will deliver on many years of GOP campaign promises to reform the health care system. I have no doubt well pass this because were going to keep our promises, Ryan said at a news conference following 24 hours of conservative backlash against the bill. This is a monumental, exciting conservative reform, Ryan said. Ive been working on this for 20 years. This is exciting. This is what weve been dreaming about doing. Lawmakers gathered in two House committees Wednesday to begin working on the legislation, which has also received pushback from moderates in the Senate and key health -care industry stakeholders since it was released on Monday.

Conservative caucus says Ryan doesnt have the votes -The Hill: House Freedom Caucus members saidTuesday the GOPs ObamaCare repeal and replace plan does not have the votes necessary to pass the lower chamber.The 40-member conservative caucus didnt take a formal position on the GOPs plan at their meetingTuesdaynight, but several members indicated afterward that they would not support it. The House needs 218 votes to pass the bill, meaning Republicans can only lose 20 members.

Cotton says TrumpCare plan moving too fast: Thats what we did with ObamaCare -WashEx:Arkansas Sen.Tom Cottonbelieves Republicans are moving too quickly on healthcare reform and the process is reminding him a lot of what was done in order to pass the Affordable Care Act that Republicans opposed.Were moving a bit too quickly on healthcare reform, [said on MSNBC Wednesday]. This is a big issue. This is not like the latest spending bill were going to live with healthcare reform forever. He added, I dont think we need to introduce legislation on Monday and have one chance to amend it on Wednesday. Thats what we did with Obamacare.

Physician, medical organizations slam plan -Forbes: Providers of medical care, including the American Medical Association, that have benefited from millions of paying customers under the Affordable Care Act have come out strong against the GOP-led U.S. House of Representatives American Health Care Act, also known as Trumpcare with the AMA calling it critically flawed, harming vulnerable populations. The AMA joined a chorus of groups, including the American Hospital Association and the American Academy of Family of Physicians, bemoaning the House bills lack of coverage, financial details and transparency.

AARP moves to kill bill -The Hill:AARP is going on the warpath against the Republican proposal to repeal and replace ObamaCare. The lobbying group for seniors accused House Republican leaders of crafting legislation that increases insurance premiums for consumers, while giving a sweetheart deal to big drug companies and special interests. Although no one believes the current health care system is perfect, this harmful legislation would make health care less secure and less affordable, saidNancy LeaMond, AARPs executive vice president, said in a statement.

Going it alone: Corporate bigs chart own course on health care -WSJ: Plans include prescription-drug contracts with CVS and UnitedHealth, using IBMs Watson to analyze data. A U.S. alliance formed last year by more than three dozen companies, including American Express Co., Johnson & Johnson and Macys Inc., is announcing its first plans aimed at lowering the companies health-care spending.

[Ross Douthatexplainswhy Republicans are so bad at health care legislation.]

THE RULEBOOK: LOOKING AT YOU CALIFORNIA When the dimensions of a State attain to a certain magnitude, it requires the same energy of government and the same forms of administration which are requisite in one of much greater extent.Alexander Hamilton,Federalist No. 13

TIME OUT:SO TIGERS CAN CHANGE THEIR STRIPES? Nat Geo:Spring is coming, and as some of us prepare to trade snowsuits for swimsuits, we may find a few extra pounds under our winter coats. Animals are smart. They never take their coats off. But what does animal skin look like under fur or hairespecially strikingly patterned animals such asbig catsandzebras? The short answer is it depends on the animal. All mammalian hair color is dictated by melanin-producing cells, called melanocytes, that live within hair follicles. Melanocytes that live between follicles control skin color, saysGreg Barsh, a geneticist at Hudson Alpha Biotechnology Institute in Huntsville, Alabama.The two systems are controlled by different genes, hormones, and other factors, says Barsh, who studies the genetics of animal color patterns.

Flag on the play? -Email us atHALFTIMEREPORT@FOXNEWS.COMwith your tips, comments or questions.

WHODUNNIT? CIA CHASING CULPRIT IN DAMAGING BREACH Reuters: U.S. intelligence and law enforcement officials said on Wednesday that they have been aware since the end of last year of a security breach at the CIA that led to anti-secrecy group WikiLeaks publishing agency documents on its hacking tools. The officials, who asked not to be identified, told Reuters that they believed that the documents published by WikiLeaks on Tuesday were authentic. Investigators were focusing on CIA contractors as the likely source of passing materials to WikiLeaks, the officials said. The group published what it said were nearly 8,000 of pages of internal CIA discussions about hacking techniques used between 2013 and 2016.

Cyber contractor warns of more to come: heavy s--- coming down -Fox News: A day after WikiLeaks released what it alleged to be the entire hacking capacity of the CIA, the focus Wednesday began shifting to just who gave the stunning surveillance information to [WikiLeaks]. There is heavy s--- coming down, said a veteran cyber contractor for the intelligence community who previously worked in the breached unit, the CIAs Center for Cyber Intelligence.

[Applesresponseto the Wiki dump? Keep your security software updated.]

SENATE JUDICIARY COMMITTEE TO TEST TRUMPS CLAIM OF WIRETAPS AP: The leaders of a congressional inquiry into Russias efforts to sway the U.S. election called on the Justice Department Wednesday to produce any evidence that supports President Donald Trumps explosive wiretapping allegation. Declaring that Congress must get to the bottom of Trumps claim, Sens.LindseyGraham, R-S.C., andSheldonWhitehouse, D-R.I., asked Acting Deputy Attorney General Dana Boente and FBI Director James Comey to produce the paper trail created when the Justice Departments criminal division secures warrants for wiretaps. ILL TELL YOU WHAT: HEALTH FIBS AND PANDA RIBS DanaPerinoandChrisStirewaltlook back on how we got ObamaCare and where Republicans go next. And how about those claims of wiretapping? Our duo break it all down. Plus, Dana talks about her upcoming trip with Mercy Ships while Stirewalt further pushes the acceptable boundaries of acceptable food items.WATCH HERE.

AUDIBLE: YAY? Youre stuck with me for another six and a half years. FBI DirectorJames Comeyat a Boston College law enforcement conference affirming his intention to serve out a full term, despite being dogged by political controversy for months.

PLAY-BY-PLAY Trump taps former Bush lawyerNoel Franciscoas solicitor general as part of new high-powered legal team-WashEx

Perdue, Cotton say Trump is onboard with their plan to clamp down on legal immigration -Politico

Bipartisan Senators sign letter asking Trump to address bomb threats against Jewish groups -Time

Q Poll: 81 percent of Republicans agree with Trump that the press is the enemy of the American people -Quinnipiac University

NERD BRACKET: THE FLOURISHING FOUR Its down to four. And what a quartet it is.

Thanks to the hundreds of voters who have helped us get to the semifinals of our bracket challenge for great American political oratory. But now were heading down to two and, our grand champion.

Submit your winning choices for each of the two brackets listed below toHALFTIMEREPORT@FOXNEWS.COMbefore Friday at noon ET to have your voice heard. The winner of the championship will be determined by which of the two finalists got the most votes in this round.

1) a)Abraham Lincoln: Gettysburg address (1863) b)George Washington: Farewell address (1796)

2) a)Ronald Reagan:The Boys of Pointe du Hoc (1984) b)Patrick Henry: Give me Liberty or Give me Death (1775)

When you send in your submission toHALFTIMEREPORT@FOXNEWS.COM, you can just list the corresponding number before the entry.

[Ed. note: A sample entry would look like this: 1b, 2a]

The Gettysburg Address is simply far and away the predominant speech ever given by any American. What boggles the mind is that Mr. Lincoln was basically a self-educated man who studied word and sentence structure via the classics in order to hone those skills he felt he would need in a courtroom. That he mastered those skills we hold to be self-evident. (Sorry, couldnt help myself there). BrettCarls, Prescott Valley, Ariz.

[Ed. note: Lincoln may have been self-educated in large part, but his source material was pretty great. The collected plays ofWilliamShakespeareand the King James Bible would be a good enough grounding for even a prairie boy with dreams of great things. One of the hallmarks of Lincoln in his youth was his insatiable appetite for books and reading. He famously had to work for a neighbor to pay off the debt of a book that had become damaged by water and was also said to keep a slim volume in his back pocket while plowing so he could pause at the end of a row to turn a few pages. Needless to say, this was not common practice in the frontier woods of Indiana.]

I think people favor the impact of things theyve personally experienced. I especially wish citizens were more familiar with Lincolns second inaugural address, which is a masterpiece of healing and of accepting corporate responsibility for institutional sins. If only he were here for the immigration debate! KathyNesper, Long Beach, Calif.

[Ed. note: You could hardly be more right, Ms. Nesper. Appreciation and proximity often go together. But even at a distance so great as ours to the spring of 1865 the power and significance of Lincolns words to a nation at the end of its most horrible struggle sound a powerful note in any human heart.]

For us oldsters, Patrick Henrys speech represents the real American spirit of freedom. Of course, my ancestors (Virginia first generation 1720s) were more than likely non-players on either side Quakers I think. MikeWilmore, Driftwood Texas

[Ed. note: Henrys challenge to his fellow Virginia burgesses is a stark one, especially for Americans today who daily wrestle with the balance between liberty and comfort. Henrys argument was that no amount of concessions from the crown would be worth sacrificing the inherent freedom granted by God to all human kind. Very little discussion in America today centers on the discussion of freedom for its own sake. I wonder about its chances in the final pairings since the language is not just archaic, but unfamiliar to the ears of many today.]

Your second bracket of the second round, Ronald Reagans The Boys of Pointe du Hoc (1984) v. Abraham Lincolns Second Inaugural Address (1865) appears to be the exact same pairing from the first round.Admittedly, I know very little about sports, so if theres something Im missing please forgive this email! I love the Halftime Report--thank you so much for your witty and informative writing. A fellow Mountaineer. SusanKescenovitz, Sheboygan, Wisc.

[Ed. note: You are right and our listing was in error. But it is too late now to start again. We transposed Reagans entries and ended up with a different, more beautiful, but less historically significant entry for the 40thpresident. Even so, the Gipper is represented, and with a speech that was good enough to get him in to the final four. Were sorry for the error, but glad that it didnt affect the outcome.]

Great idea to do a Worst Speeches Ever andJimmy Carters Malaise speech should definitely make the Sour Sixteen.I also nominateBill Clintons 1988 keynote speech to the 1988 Democratic National Convention when he was still Governor of Arkansas. It went on forever and ever and ever. It was supposed to last 15 minutes and instead lasted 33 minutes. I grew a full beard as I listened. The crowd actually cheered when he said In conclusion . . . DuaneBrown, Decherd, Tenn.

[Ed. note: If only politicians could learn that excellence and duration are usually inversely correlated when it comes to political oratory!]

Shareyour color commentary:Email us atHALFTIMEREPORT@FOXNEWS.COMand please make sure to include your name and hometown.

HE ONLY READS IT FOR THE ORDINANCES Panama City News Herald:The city of [Springfield, Fla.s] former website has been taken over by some questionable content. Last week the city began receiving complaints from citizens who were visiting the citys old website. Our main website is springfield.fl.gov, and if the citizens go to (the old website), it now goes to a porno site, MayorRalph Hammondsaid. Hammond said the city apparently let the domain name expire, and the site now contains Japanese pornography. The citys IT department now is seeking to buy back the domain and any domains names similar to the citys current springfield.fl.gov website. Hammond said the city will keep its .gov website and will have a year to buy back the old domain. Its quite embarrassing, Hammond said. I had one gentleman call and say, Im not voting for you anymore because you got porn on the city website.

AND NOW, A WORD FROM CHARLES But the real story is I think this is worse than [Edward]Snowden. Its one thing to disclose names and places and even operations, but once you are describing the sources and methods, thats the key to what we do. -CharlesKrauthammeron Special Report withBretBaier.

ChrisStirewaltis the politics editor for Fox News.SallyPersonscontributed to this report. Want FOX News Halftime Report in your inbox every day? Sign uphere.

Chris Stirewalt joined Fox News Channel (FNC) in July of 2010 and serves as digital politics editor based in Washington, D.C. Additionally, he authors the daily "Fox News First" political news note and hosts "Power Play," a feature video series, on FoxNews.com. Stirewalt makes frequent appearances on the network, including "The Kelly File," "Special Report with Bret Baier," and "Fox News Sunday with Chris Wallace." He also provides expert political analysis for Fox News coverage of state, congressional and presidential elections.

Follow this link:
Will Trump stick with TrumpCare? - Fox News

Posted in Arkansas Stem Cells | Comments Off on Will Trump stick with TrumpCare? – Fox News

Opinion: Harry Boxer’s six biotechnology stocks to watch – MarketWatch

Posted: March 9, 2017 at 6:46 am

While the broader stock market fell Monday, many biotech shares continued to outperform.

The big mover was TG Therapeutics Inc. TGTX, -6.88% which soared 90% after releasing positive results from its Phase 3 clinical trial of its treatment for high-risk leukemia patients. The stock closed up $4.85 to $10.20 on 33.7 million shares, which is 34 times its daily average. The stock blew through several layers of resistance, but pulled back at the close below resistance from the April high at around $10.50. A breakthrough there should get the stock to $13 and then $15. Support is at the days low of $9.10 and then $8. Short interest of 22 times its average volume could accelerate the advance.

Concert Pharmaceuticals Inc. CNCE, +5.11% rocketed 62% Monday on news that Vertex Pharmaceuticals Inc. VRTX, +0.94% will be acquiring the companys cystic fibrosis drug, CTP-656. The stock closed at $15.64, up $5.99, at around the mid-range of the days action, which bodes well for a follow-through. Volume of 10.5 million shares was more than 85 times its average. Watch for a retest the days intraday high at $18.48, a breakthrough that could get the stock moving to test its highs from November 2015 at just under $25.

Kite Pharma Inc. KITE, +1.90% which we highlighted in our biotech article on Friday, followed through on Monday, up $1.37 to $73.90. FBR Capital mentioned the company in a research note in which it said that potential tax reform and FDA policy changes under President Trump could fuel acquisitions of clinical-stage biotech companies. RBC Capital Markets boosted its price target from $85 to $95. KITE surged last week after the company released a favorable earnings report and positive clinical data on its lead product candidate for treating patients with rare forms of blood cancer. Pulling back slightly on Thursday and Friday, the stock is now in a high-level mini-wedge formation, a break of which could lead to the next target at $90.

Amicus Therapeutics Inc. FOLD, +2.85% was relatively flat on Monday, down just 10 cents to $7.69, but is looking strong. As we noted in our article Friday, the stock rocketed 17% on Wednesday after the company CEOs daughter, Megan Crowley, who has Pompe disease, was highlighted during President Trumps address to Congress Tuesday night. The stock has broken out of a mini-consolidation pattern and across lateral resistance from its December high. At its intraday highs last week, the stock nearly reached the level it was at before its big gap down in December. If it can fill that gap, watch for a move next to $9.50.

Among other biotechs to watch, Supernus Pharmaceuticals Inc. SUPN, +5.30% reached a new all-time at $30.37 on Monday, before closing at $29.75, still up $1 in a down market. The drugmaker has been rallying in the past week since topping analysts forecasts in its fourth-quarter report last Wednesday. Watch for $32-$33 in the short term.

Foundation Medicine Inc. FMI, +2.49% gained $3, or 10.6%, to $31.30 on no news Monday. Stock in the diagnostic cancer analyses company has been up six days in a row since closing at $23.10 on Feb. 24. The rally has broken the stock out of a falling wedge pattern. Our initial target of $29 was exceeded Monday, and next target is near $35.

See Harrys video-chart analysis on these stocks.

The writer has no holdings in any securities mentioned.

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

See the original post here:
Opinion: Harry Boxer's six biotechnology stocks to watch - MarketWatch

Posted in Biotechnology | Comments Off on Opinion: Harry Boxer’s six biotechnology stocks to watch – MarketWatch

CMBG Receives US$2.29 Million Grant For Stem Cell Therapy – Asian Scientist Magazine

Posted: March 9, 2017 at 6:43 am

Chinas Cellular Biomedicine Group has received US$2.29 million to support pre-clinical studies of stem cell therapy for knee osteoarthritis.

Asian Scientist Newsroom | March 9, 2017 | Pharma

AsianScientist (Mar. 9, 2017) - Cellular Biomedicine Group Inc., a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases, has been awarded US$2.29 million by the governing Board of the California Institute for Regenerative Medicine (CIRM) to support pre-clinical studies of AlloJoin, CBMGs Off-the-Shelf allogeneic human adipose-derived mesenchymal stem cells for the treatment of knee osteoarthritis in the United States.

While CBMG recently commenced two Phase I human clinical trials in China using CAR-T to treat relapsed/refractory CD19+ B-cell acute lymphoblastic leukemia (ALL) and refractory diffuse large B-cell lymphoma (DLBCL) as well as an ongoing Phase I trial in China for AlloJoin in knee osteoarthritis, this latest announcement represents CBMGs initial entrance into the United States for its off-the-shelf allogeneic stem cell candidate AlloJoin.

The US$2.29 million was granted under the CIRM 2.0 program, a comprehensive collaborative initiative designed to accelerate the development of stem cell-based treatments for people with unmet medical needs. After the award, CIRM will be a more active partner with its recipients to further increase the likelihood of clinical success and help advance a pre-clinical applicants research along a funding pipeline towards clinical trials.

CBMGs knee osteoarthritis pre-clinical program is considered late-stage, and therefore it meets CIRM 2.0s intent to accelerate support for clinical stage development for identified candidates of stem cell treatments that demonstrate scientific excellence.

We are deeply appreciative to CIRM for their support and validation of the therapeutic potential of our knee osteoarthritis therapy, said Mr. Tony (Bizuo) Liu, Chief Executive Officer of CBMG. The CIRM grant is the first step in bringing our allogeneic human adipose-derived mesenchymal stem cell treatment for knee osteoarthritis (AlloJoin) to the U.S. market.

In order to demonstrate comparability with cell banks previously produced in China for our U.S. IND filing, we are addressing the pre-clinical answers required for the FDA. With the funds provided by CIRM, we will replicate and validate the manufacturing process and control system at the cGMP facility located at Childrens Hospital Los Angeles to support the filing of an IND with the FDA.

CBMG recently announced promising interim three-month safety data from its Phase I clinical trial in China for AlloJoin, its off-the-shelf allogeneic stem cell therapy for knee osteoarthritis. The trial is on schedule to be completed by the third quarter of 2017.

Source: Cellular Biomedicine Group Inc; Photo: Shutterstock. Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Read this article:
CMBG Receives US$2.29 Million Grant For Stem Cell Therapy - Asian Scientist Magazine

Posted in Cell Therapy | Comments Off on CMBG Receives US$2.29 Million Grant For Stem Cell Therapy – Asian Scientist Magazine

Can sweat patches revolutionise diabetes? – BBC News

Posted: March 9, 2017 at 6:42 am

Can sweat patches revolutionise diabetes?
BBC News
And in extra tests on mice, the sensor was hooked up to a patch of tiny needles to automatically inject diabetes medication. The team at the Seoul National University were trying to overcome the need for "painful blood collection" needed in diabetes ...

and more »

Continue reading here:
Can sweat patches revolutionise diabetes? - BBC News

Posted in Diabetes | Comments Off on Can sweat patches revolutionise diabetes? – BBC News

MannKind Corp. to sponsor TV series on tackling diabetes – Santa Clarita Valley Signal

Posted: March 9, 2017 at 6:42 am

MannKind Corp. will sponsor a new television series this summer on the effects of poorly managed diabetes and its impact on people with the disease.

Reversed will air on Discovery Life Channel. It was created and will be hosted by Charles Mattocks, a celebrity chef and diabetes advocate.

MannKind is continually seeking platforms to increase awareness around the challenges, opportunities and success people living with diabetes encounter on a daily basis, said Michael Castagna, the companys chief commercial officer, in a statement.

The show will follow the lives of individuals affected by diabetes and their struggle to change their diet, exercise and mindset about the disease. It will feature experts such as diabetes educators, endocrinologists, therapists, nutritionists, and trainers, as well as celebrity guests who are also living with diabetes, to help encourage the contestants.

Mattocks, a nephew of Bob Marley, said, My uncle made an impact on the world through music and my vision is to impact health. Reversed is about changing the behavior of those with diabetes.

MannKind, the Valencia-based maker of Afrezza, an inhalable form of insulin, is working with Mattocks production company, Bella & Elle Media LLC.

Read more from the original source:
MannKind Corp. to sponsor TV series on tackling diabetes - Santa Clarita Valley Signal

Posted in Diabetes | Comments Off on MannKind Corp. to sponsor TV series on tackling diabetes – Santa Clarita Valley Signal

Merck aims to put Amazon’s Alexa to work on voice-enabled diabetes tools – FiercePharma

Posted: March 9, 2017 at 6:42 am

Alexa? Help pharma find patient solutions.

Thats what Merck & Co. is aiming for in its new partnership with Amazon Web Services to developdigital voice-enabled solutions for people living with chronic diseases.

Using Amazon Lex, the brains behind the Amazon Echo device and its well-known voice-enabled assistant Alexa, Merck plans to initially work on diabetes. Its first initiative will be a call to entrepreneurs, techies and industry types foran innovation challenge expected to begin within the next month.

The yet-to-be-named challenge will be run by strategy and innovation consultancyLuminary Labs. While specifics havent been released, the call to action will be open to solutions broadly enough that innovators of all stripes can come up with really novel ideas but being narrow enough to provide guidance and carefully evaluate submissions, said Sara Holoubek, founder and CEO of Luminary Labs.

An independent jury will evaluate the submissions based on their use ofvoice-enabled technology thataddresses Type 2 diabetes patient issues.

Merck's long-term planis to create tools for otherchronic diseases using the same Amazon Lex platform and the voice-enabled Alexa home system.

Analysts estimate Amazon will sell more than 110 million Amazon Echo devices over the next four years, and many are already pointing to healthcare as an important item on Alexa'seventual to-do list.

Users will soon go far beyond turning on lights or calling an Uber, and will venture deeper into healthcare, helping people better manage treatments and communicate with caregivers," Luminary noteson its website. "From reminding people of their nutrition plans to scheduling their insulin dosages, the Merck-sponsored Alexa challenge will call on developers to push the boundaries of voice technology for people with diabetes."

See more here:
Merck aims to put Amazon's Alexa to work on voice-enabled diabetes tools - FiercePharma

Posted in Diabetes | Comments Off on Merck aims to put Amazon’s Alexa to work on voice-enabled diabetes tools – FiercePharma

Health Check: Research into diabetes complication – Turn to 10

Posted: March 9, 2017 at 6:42 am

by BARBARA MORSE SILVA, NBC 10 NEWS

New biomedical research shows promise in fighting a complication of diabetes.

Richard Clements, Ph.D., is an assistant professor at Brown University and one of the researchers on this project, which was recently funded by the Brown University-based Advance Clinical and Translational Research initiative.

The lab-based, very preliminary research is looking at the vascular system in diabetics and why the blood vessels dont always dilate to accommodate increased blood flow. Thats important for several reasons.

"That can lead to a whole host of problems, said Clements. Vascular problems, coronary artery disease, peripheral vascular disease as well as higher blood pressure."

As part of this research, discarded tissue from diabetic and non-diabetic patients is being used.

"That we can then take and mount in this set up and then we can give it all sorts of drugs without having to worry about patient safety because it's not in the patient anymore," explained Clements.

And then they can, in this lab, measure which drugs improve the condition. Right now, this research is only in the lab. But, eventually, it will involve animal and then human testing.

"This is kind of the beginning stages of what could, 10 years down the line, turn into some sort of treatment," said Clements.

This is one of the first pilot awards from the Brown University-based Advance Clinical Translational Research initiative, which received funding from the National Institute of General Medical Sciences.

The total of this five-year program award is $19.5 million. Its purpose is to fund collaborative research involving multiple partners, depending on the project, including researchers from Brown University, Lifespan, Care New England, the Providence VA Medical Center, URI and the Rhode Island Quality Institute.

Originally posted here:
Health Check: Research into diabetes complication - Turn to 10

Posted in Diabetes | Comments Off on Health Check: Research into diabetes complication – Turn to 10

Poor Diet Tied to Heart Disease, Diabetes Deaths – WebMD

Posted: March 9, 2017 at 6:42 am

By Karen Pallarito

HealthDay Reporter

TUESDAY, March 7, 2017 (HealthDay News) -- Nearly half of all deaths from heart disease, stroke and diabetes in the United States are associated with diets that skimp on certain foods and nutrients, such as vegetables, and exceed optimal levels of others, like salt, a new study finds.

Using available studies and clinical trials, researchers identified 10 dietary factors with the strongest evidence of a protective or harmful association with death due to "cardiometabolic" disease.

"It wasn't just too much 'bad' in the American diet; it's also not enough 'good,'" said lead author Renata Micha.

"Americans are not eating enough fruits, vegetables, nuts/seeds, whole grains, vegetable oils or fish," she said.

Micha is an assistant research professor at the Tufts University School of Nutrition Science and Policy in Boston.

The researchers used data from multiple national sources to examine deaths from cardiometabolic diseases -- heart disease, stroke and type 2 diabetes -- in 2012, and the role that diet may have played.

"In the U.S. in 2012, we observed about 700,000 deaths due to those diseases," Micha said. "Nearly half of these were associated with suboptimal intakes of the 10 dietary factors combined."

Too much salt in people's diets was the leading factor, accounting for nearly 10 percent of cardiometabolic deaths, according to the analysis.

The study identifies 2,000 milligrams a day, or less than 1 teaspoon of salt, as the optimal amount. While experts don't agree on how low to go, there is broad consensus that people consume too much salt, Micha noted.

Other key factors in cardiometabolic death included low intake of nuts and seeds, seafood omega-3 fats, vegetables, fruits and whole grains, and high intake of processed meats (such as cold cuts) and sugar-sweetened beverages.

Each of these factors accounted for between 6 percent and 9 percent of deaths from heart disease, stroke and diabetes.

"Optimal" intake of foods and nutrients was based on levels associated with lower disease risk in studies and clinical trials. Micha cautioned that these levels are not conclusive. Optimal intake "could be modestly lower or higher," she explained.

Low consumption of polyunsaturated fats (found in soybean, sunflower and corn oils) accounted for just over 2 percent of cardiometabolic deaths, according to the study. High consumption of unprocessed red meats (such as beef) was responsible for less than one half of 1 percent of these deaths, the analysis showed.

The take-home message: "Eat more of the good and less of the bad," Micha said.

Vegetable intake, for example, was considered optimal at four servings per day. That would be roughly equivalent to 2 cups of cooked or 4 cups of raw veggies, she said.

Fruit intake was deemed optimal at three daily servings: "For example, one apple, one orange and half of an average-size banana," she continued.

"And eat less salt, processed meats, and sugary-sweetened beverages," she said.

The study also found that poor diet was associated with a larger proportion of deaths at younger versus older ages, among people with lower versus higher levels of education, and among minorities versus whites.

Dr. Ashkan Afshin is acting assistant professor of global health at the University of Washington's Institute for Health Metrics and Evaluation.

"I commend the current study's authors for exploring sociodemographic factors, like ethnicity and education, and their role in the relationship of diet with cardiometabolic disease," said Afshin, who was not involved in the study.

"This is an area that deserves more attention so that we may fully understand the connection between diet and health," he said.

The study doesn't prove that improving your diet reduces risk of death from heart disease, stroke and diabetes, but suggests that dietary changes may have an impact.

"It is important to know which dietary habits affect health the most so that people can make healthy changes in how they eat and how they feed their families," Afshin said.

The study was published March 7 in the Journal of the American Medical Association.

In an accompanying journal editorial, researchers from Johns Hopkins University urged caution in interpreting the findings.

According to Noel Mueller and Dr. Lawrence Appel, the results may be biased by the number of dietary factors included, the interaction of dietary factors and the authors' "strong assumption" that evidence from observational studies implies a cause-and-effect relationship.

Still, the editorialists concluded that the likely benefits of an improved diet "are substantial and justify policies designed to improve diet quality."

WebMD News from HealthDay

SOURCES: Renata Micha, R.D., Ph.D., assistant research professor, Friedman School of Nutrition Science and Policy, Tufts University, Boston; Ashkan Afshin, M.D., Sc.D., acting assistant professor of global health, Institute for Health Metrics and Evaluation, University of Washington, Seattle; March 7, 2017, Journal of the American Medical Association

Continued here:
Poor Diet Tied to Heart Disease, Diabetes Deaths - WebMD

Posted in Diabetes | Comments Off on Poor Diet Tied to Heart Disease, Diabetes Deaths – WebMD

Northern California Stem Cell Treatment Center in Redding, CA

Posted: March 8, 2017 at 6:44 am

100+ Treatments In The Last Year Alone In Redding

This practice is dedicated to cutting edge, highly professional procurement and delivery of autologous mesenchymal stem cells. This field is exciting for us, as well as for our affiliated physicians, and being able to offer such innovative stem cell therapy is a privilege, though it comes with great responsibility.

The Northern California Stem Cell Treatment Center is partnered with a large global organization called Cell Surgical Network. This affiliation, involving over 50 centers worldwide, shares our passion for this work and allows our practice and our patients the ability to add consequentially to the scientific knowledge base in clinical stem cell treatments.

We are pleased to be able to utilize our over 90 years of combined experience and expertise in treating patients to help forge progress in this exciting type of medicine, and we are dedicated to safely delivering stem cell therapy to our patients. We've been treating patients in Redding for over a year and seen more than 100 cases come through our office.Though the advancements thus far have been phenomenal,we are on the cusp of even greater life-changing medical innovations.

Original post:
Northern California Stem Cell Treatment Center in Redding, CA

Posted in California Stem Cells | Comments Off on Northern California Stem Cell Treatment Center in Redding, CA

Area high schools to offer dual credit biotechnology courses through Ivy Tech – Greene County Daily World

Posted: March 8, 2017 at 6:42 am

Several area high schools will start offering students the opportunity to take dual credit courses through Ivy Tech and earn free college credit this spring.

Last fall, Ivy Tech Community College Bloomington was awarded a Perkins Competitive Grant from the Indiana Department of Education, worth $85,000, to increase rural career and technical education pathways in biotechnology, according to Cook Medical Content Specialist, Moriah Sowders.

The course will be available to students attending Brown County, Owen Valley, Eastern Greene and Bloomfield high schools.

Currently, the courses are taught by an Ivy Tech instructor, though the grant will also provide training for high school science teachers to begin teaching the course in the 2017-18 school year.

In an article previously published by the Greene County Daily World, Bloomfield Jr./Sr. High School announced it would begin piloting two courses, BIOT (biotechnology) 102, the survey of good manufacturing practices, in the fall semester beginning on Jan. 17, and BIOT 100, the survey of biotechnology in the spring semester.

Eastern Greene Principal Doug Lewis said a course began there in mid January and has been going well.

It helps prepare them for going into that field, they can get a leg up going into other classes or straight into the workforce, said Lewis.

Currently, Lewis said the course is taught by an instructor from Ivy Tech once a week, and the students also login online daily for course work. The course will be offered by an Eastern Greene teacher next semester, according to Lewis.

Cook Pharmica also provided an additional $15,000 to Ivy Tech Bloomington to help launch and sustain the program in the future by providing funding for textbooks which can then be reused by participating high schools.

We have a mission at Ivy Tech Bloomington to help fill the local industry skills gap, and one way we do that is through partnerships like this with Cook Pharmica, said Jennie Vaughan, chancellor at Ivy Tech Bloomington. With the help of this grant, high school students can take dual credit classes in biotechnology, developing a clear pathway toward employment in the life sciences, an industry thats thriving in our region.

Tedd Green, president of Cook Pharmica said, We appreciate the work Ivy Tech does to help students in the local community develop the skills they need to enter the workforce upon graduating high school. This program is a true community partnership that supports the education of our local youth and the workforce development needs of the growing life sciences industry in South Central Indiana. We are pleased to be a partner in this program.

According to Sowders, Cook Pharmica has grown to 715 employees and introduced its new My Cook Pathway education assistance program in 2016, which provides employees the opportunity to continue their education at no cost to them from day one when with the company.

To find out more information about Cook Pharmica visit http://www.cookpharmica.com or to find out more information about Ivy Tech Community College visit http://www.ivytech.edu

Follow this link:
Area high schools to offer dual credit biotechnology courses through Ivy Tech - Greene County Daily World

Posted in Biotechnology | Comments Off on Area high schools to offer dual credit biotechnology courses through Ivy Tech – Greene County Daily World

Page 1,647«..1020..1,6461,6471,6481,649..1,6601,670..»